Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

about

Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets

P2860

Q39249504-19B124FA-55E0-4B23-9D26-1498F07C6E3C Q41019883-3F61A413-4484-4150-8B0A-8119D114796C Q58699651-B93D2C7B-E42B-4FC6-BD77-6C536B46A97B

P2860

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

Item

http://www.wikidata.org/entity/Q41475075

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Loss of interleukin 33 express ...... mission in ulcerative colitis.

@en

type

Item

label

Loss of interleukin 33 express ...... mission in ulcerative colitis.

@en

prefLabel

Loss of interleukin 33 express ...... mission in ulcerative colitis.

@en

P1476

Loss of interleukin 33 express ...... mission in ulcerative colitis.

@en

P2093

Jon Florholmen

http://www.w3.org/2001/XMLSchema#string

Mona Dixon Gundersen

http://www.w3.org/2001/XMLSchema#string

Renathe Rismo

http://www.w3.org/2001/XMLSchema#string

Trine Olsen

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules

Infliximab for induction and maintenance therapy for ulcerative colitis

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

Unravelling the pathogenesis of inflammatory bowel disease

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

IL-33 is a crucial amplifier of innate rather than acquired immunity

Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease.

P2888

srep35403

P304

35403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP35403

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sveinung Wergeland Sørbye

P577

2016-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27748438

http://www.w3.org/2001/XMLSchema#string

P932

5066310

http://www.w3.org/2001/XMLSchema#string

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

about

P2860

P2860

Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P698

P932